<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>63</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Deng Z</submitter><pubmed_abstract>This study was aimed to evaluate the potential function of circ-0001946 in the progression of colorectal cancer (CRC) and the related regulatory mechanism. First, the expression levels of circRNA_0001946 and microRNA-135a-5p (miR-135a-5p) in normal and CRC tissues were measured by quantitative real-time polymerase chain reaction (RT-qPCR). In addition, cell proliferation was assessed by the Cell Counting Kit-8 (CCK-8) assay, cell migration and invasion were evaluated by Transwell assays, and the cell cycle patterns were determined by flow cytometry. The relationship between the expression levels of circ_0001946 and miR-135a-5p was determined by dual-luciferase reporter assays. Our data showed that the expression of circ_0001946 was upregulated in CRC tissues, which was negatively correlated with tumor size, histologic grade, lymphatic metastasis, and TMN stage, and patients with circ_0001946 overexpression were more likely to have a poor prognosis. In addition, &lt;i>in vitro&lt;/i> experiments showed that silencing circ_0001946 inhibited the epithelial-mesenchymal transition (EMT) pathway and markedly suppressed CRC cell growth, migration, and invasion. Furthermore, we discovered that the transfection of miR-135a-5p mimics could reverse the antitumor effects of circRNA_0001946 downregulation. To summarize, this study revealed that circRNA_0001946 might act as a tumor promoter by activating the miR-135a-5p/EMT axis and may be a promising treatment target for CRC.</pubmed_abstract><journal>Frontiers in genetics</journal><pagination>357</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7232565</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Dysregulation of CircRNA_0001946 Contributes to the Proliferation and Metastasis of Colorectal Cancer Cells by Targeting MicroRNA-135a-5p.</pubmed_title><pmcid>PMC7232565</pmcid><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Deng Z</pubmed_authors><pubmed_authors>Cai Y</pubmed_authors><pubmed_authors>Geng Y</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><view_count>63</view_count></additional><is_claimable>false</is_claimable><name>Dysregulation of CircRNA_0001946 Contributes to the Proliferation and Metastasis of Colorectal Cancer Cells by Targeting MicroRNA-135a-5p.</name><description>This study was aimed to evaluate the potential function of circ-0001946 in the progression of colorectal cancer (CRC) and the related regulatory mechanism. First, the expression levels of circRNA_0001946 and microRNA-135a-5p (miR-135a-5p) in normal and CRC tissues were measured by quantitative real-time polymerase chain reaction (RT-qPCR). In addition, cell proliferation was assessed by the Cell Counting Kit-8 (CCK-8) assay, cell migration and invasion were evaluated by Transwell assays, and the cell cycle patterns were determined by flow cytometry. The relationship between the expression levels of circ_0001946 and miR-135a-5p was determined by dual-luciferase reporter assays. Our data showed that the expression of circ_0001946 was upregulated in CRC tissues, which was negatively correlated with tumor size, histologic grade, lymphatic metastasis, and TMN stage, and patients with circ_0001946 overexpression were more likely to have a poor prognosis. In addition, &lt;i>in vitro&lt;/i> experiments showed that silencing circ_0001946 inhibited the epithelial-mesenchymal transition (EMT) pathway and markedly suppressed CRC cell growth, migration, and invasion. Furthermore, we discovered that the transfection of miR-135a-5p mimics could reverse the antitumor effects of circRNA_0001946 downregulation. To summarize, this study revealed that circRNA_0001946 might act as a tumor promoter by activating the miR-135a-5p/EMT axis and may be a promising treatment target for CRC.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2024-11-12T07:19:16.021Z</modification><creation>2020-06-09T07:05:23Z</creation></dates><accession>S-EPMC7232565</accession><cross_references><pubmed>32508871</pubmed><doi>10.3389/fgene.2020.00357</doi></cross_references></HashMap>